OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serious harms of the COVID-19 vaccines: a systematic review
Peter C Gøtzsche, Maryanne Demasi
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
Peter C Gøtzsche, Maryanne Demasi
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
Showing 13 citing articles:
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
Events supposedly attributable to vaccination or immunization of COVID-19 vaccines in Brazil: a cross-sectional study
Paloma Cristina Pimenta, Vitoria Gabriele Souza Geraldine, Túlio M. Lima, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Paloma Cristina Pimenta, Vitoria Gabriele Souza Geraldine, Túlio M. Lima, et al.
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases, in Patients with Cardiac Issues, and in the Healthy Population
Loredana Frasca, Giuseppe Ocone, Raffaella Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 233-233
Open Access | Times Cited: 10
Loredana Frasca, Giuseppe Ocone, Raffaella Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 233-233
Open Access | Times Cited: 10
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
Peter Rhodes, Peter Parry
International Journal of Risk & Safety in Medicine (2024) Vol. 35, Iss. 4, pp. 317-333
Closed Access | Times Cited: 2
Public Health Needs the Public Trust: A Pandemic Retrospective
Matthew Halma, Joshua Guetzkow
BioMed (2023) Vol. 3, Iss. 2, pp. 256-271
Open Access | Times Cited: 7
Matthew Halma, Joshua Guetzkow
BioMed (2023) Vol. 3, Iss. 2, pp. 256-271
Open Access | Times Cited: 7
Vaccine disinformation from medical professionals—a case for action from regulatory bodies?
David Robert Grimes, Trisha Greenhalgh
Journal of Evaluation in Clinical Practice (2024) Vol. 30, Iss. 4, pp. 632-637
Open Access | Times Cited: 1
David Robert Grimes, Trisha Greenhalgh
Journal of Evaluation in Clinical Practice (2024) Vol. 30, Iss. 4, pp. 632-637
Open Access | Times Cited: 1
A risk science perspective on the COVID-19 risk handling
Terje Aven
Journal of Risk Research (2024) Vol. 27, Iss. 3, pp. 337-355
Open Access | Times Cited: 1
Terje Aven
Journal of Risk Research (2024) Vol. 27, Iss. 3, pp. 337-355
Open Access | Times Cited: 1
COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy
Heidi N. du Preez, Johnson Lin, Glenn E. M. Maguire, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 1
Heidi N. du Preez, Johnson Lin, Glenn E. M. Maguire, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 1
Commentary: raised c-troponin levels as a sign of myocardial injury after COVID-19 vaccination in healthy individuals are worrying
Rainer J. Klement, Harald Walach
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access
Rainer J. Klement, Harald Walach
The Egyptian Heart Journal (2024) Vol. 76, Iss. 1
Open Access
What Next for Covid-19 Vaccines? Increasing Resistance, Safety Fears, Generalized Mistrust, Censorship and Surveillance
David F Marks
Journal of Clinical & Experimental Immunology (2023) Vol. 8, Iss. 2
Open Access
David F Marks
Journal of Clinical & Experimental Immunology (2023) Vol. 8, Iss. 2
Open Access
